Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
BRISTOL-MYERS SQUIBB COMPANY	ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NEW JERSEY 08543 UNITED STATES OF AMERICA

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• G01N:INVESTIGATING OR ANALYSING MATERIALS BY DETERMININ....
• C07K:PEPTIDES

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Allen, Martin Patrick	Flemington, US	22	228
Bowsher, Michael S	Prospect, US	26	172
Boy, Kenneth M	Durham, US	34	330
Gillis, Eric P	Cheshire, US	58	312
Langley, David R	Meriden, US	54	1249
Miller, Michael Matthew	Lambertville, US	10	172
Mull, Eric	Guilford, US	30	328
Reid, Patrick C	Tokyo, JP	8	120
Scola, Paul Michael	Glastonbury, US	101	2080
Sun, Li-Qiang	Glastonbury, US	57	943
Yeung, Kap-Sun	Madison, US	67	826

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Jul 30, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jul 30, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
January 30, 2018	US,9879046,B2   US9879046B2	GRANTED PATENT AS SECOND PUBLICATION
November 24, 2016	US,20160340391,A1   US20160340391A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9879046

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

---

 

Legal Events